Smarter Investing for a Better World

We put the Ziggma Stock Score on trial: 2,400 stocks, 4.5 years, no cherry-picking. High scorers beat the S&P 500. Low scorers lost money in a rising market.

AbbVie replaced Humira and came out bigger, yet still trades at 18x next year's earnings while growing faster than Merck or Johnson & Johnson. Its medicines reached 210,000 Americans free of charge last year, and its climate score is 83. The patent record behind it is why impact stops at 70.

Genpact trades at 9 times next year's earnings because investors believe AI will destroy the business of running other companies' back offices. Management is building that AI itself, growing its technology segment 25% while retraining a workforce of 145,000.

Investors decided AI made Photoshop obsolete and cut Adobe 60%. It still collected $10.3 billion in cash last year, and it built the standard newsrooms use to prove a photo is real. Our base case, plus the one part of its record we are not defending.

Against all odds, there's a profitable US bank running on 100% renewable power that's up more than 50% since we flagged it in February. The cheap-valuation call has played out, so can earnings carry Amalgamated Financial (AMAL) even higher? Here's our honest read on the path to $65 to $70 and the risks Wall Street is already pricing in.

MSA Safety builds the breathing gear, gas detectors, and helmets that keep firefighters and industrial workers alive, and it has quietly turned that mission into a standout business: 25% profit growth, roughly 19% analyst upside, and a Ziggma Score of 92. Returns and real-world impact, pulling in the same direction.

Ziggma's Growth, Impact, Momentum model portfolio returned +30% in the first half of 2026 — roughly three times the S&P 500 — from ten high-quality businesses chosen for both returns and real-world impact. Here's the full mid-year, stock-by-stock breakdown of what drove it.

Samsara just flipped the switch from cash-burning startup to profitable software compounder, with earnings up 145.5% and sales growing 30% a year. The stock trades 17% below analyst targets even as its AI helps trucking fleets slash crash rates by 73% and cut billions of pounds of carbon pollution. It's a growth story with real safety and sustainability impact built right into the product.

Our High Conviction 2026 model portfolio returned +3.9% in June — comfortably ahead of a jittery S&P 500 — even as two of its biggest AI names got caught in the market's capex nerves. Here's the full stock-by-stock breakdown of what drove the month.

Alnylam has six FDA-approved RNAi therapeutics, 81% revenue growth in 2025, full-year 2026 guidance of $4.4-4.7 billion, and a PEG ratio below 1. It is newly profitable, self-funding, and building toward over 40 clinical programs by 2030. The platform that started with a Nobel Prize is just reaching commercial scale. Analysts see 44% upside. The GoodStocks case is here.

$124 trillion is changing hands by 2048, and the generation inheriting most of it already wants its money to do more than sit still. Add AI-grade impact data finally catching up to that demand, and impact investing stops being a niche — it becomes the default.

Wall Street has spent 2026 selling Salesforce. Revenue is reaccelerating, earnings are beating by 31%, and Agentforce is growing at 114% year-over-year. Analysts see 67% upside. 100% renewable. Net zero. Impact Score 87/100. Ziggma Score 95/100. The contrarian case for CRM is hiding in plain sight.

Most investors don't lose money because they pick bad stocks. They lose money because they hold bad stocks too long. This post explains how a rules-based tracking system — built around the Ziggma Score, Portfolio Beta, and Impact Analysis — removes emotion from that decision and keeps every holding accountable to your return objectives.

Climate change is one of the largest capital allocation challenges in modern history. Trillions of dollars will need to flow into energy, infrastructure, electrification, and climate solutions over the coming decades — yet the world remains far behind. The future of the climate transition may depend as much on where investors allocate capital as on government policy.

Ecolab is the world's largest water conservation company — and most investors have never heard of it. In 2024 alone, its technology helped customers save 226 billion gallons of water while a blockbuster acquisition has planted it at the heart of the AI data center cooling boom. With a Ziggma Score of 77, 21% analyst upside, and an ACA Ethos Impact Score of 70, ECL is one of the most compelling Good Stocks in the series to date.

Insulet ($PODD) is down nearly 60% from its 52-week high—yet revenue just surged 34%. Wall Street smells a massive disconnect. With 24 "Strong Buy" ratings and a 64% implied upside, this isn't a failing business; it’s a high-growth recovery play.

There are few ways to generate instant returns in investing — brokerage signup bonuses are one of them. This guide covers the most attractive offers available today and how to take advantage of more than one without losing track of what you own.

Managing investments across multiple brokers makes it nearly impossible to see your portfolio clearly. Account aggregation solves this by connecting all your accounts into a single, unified view — powered by API-based providers like Plaid and Snaptrade that use OAuth, read-only access, and bank-grade encryption. The result is full portfolio visibility without ever sharing your login credentials.